Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
NVIDIA
NVDA
$5.2T
| $225M | 0.14% |
10,866,890
-1,019,830
| -9% | -$21.2M |
|
102
Crown Holdings
CCK
$13B
| $223M | 0.13% |
2,209,928
+1,522,563
| +222% | +$160M |
|
103
Procter & Gamble
PG
$336B
| $221M | 0.13% |
1,577,337
+845,536
| +116% | +$120M |
|
104
PUT
Texas Instruments
TXN
$241B
| $219M | 0.13% |
1,138,500
-29,900
| -3% | -$5.7M |
|
105
Baxter International
BAX
$13.6B
| $214M | 0.13% |
2,656,871
+1,584,491
| +148% | +$125M |
|
106
PUT
Starbucks
SBUX
$122B
| $214M | 0.13% |
1,935,900
-145,300
| -7% | -$17M |
|
107
Palo Alto Networks
PANW
$292B
| $213M | 0.13% |
2,670,852
+1,258,476
| +89% | +$88.4M |
|
108
PUT
ServiceNow
NOW
$133B
| $211M | 0.13% |
1,694,000
+269,000
| +19% | +$32.6M |
|
109
ExxonMobil
XOM
$679B
| $211M | 0.13% |
3,580,268
+3,489,990
| +3,866% | +$199M |
|
|
XLNX
110
DELISTED
Xilinx Inc
XLNX
| $210M | 0.13% |
1,394,051
-871,282
| -38% | -$128M |
|
111
Pfizer
PFE
$160B
| $207M | 0.12% |
4,810,719
+6,957
| +0.1% | +$308K |
|
|
PPD
112
DELISTED
PPD, Inc. Common Stock
PPD
| $206M | 0.12% |
4,411,394
-552,037
| -11% | -$25.6M |
|
113
PUT
Applied Materials
AMAT
$391B
| $206M | 0.12% |
1,598,000
+47,200
| +3% | +$6.41M |
|
114
Coca-Cola
KO
$392B
| $205M | 0.12% |
3,913,668
+1,226,065
| +46% | +$68.3M |
|
115
CALL
Bank of America
BAC
$431B
| $205M | 0.12% |
4,829,600
+2,387,800
| +98% | +$96.2M |
|
116
McKesson
MCK
$100B
| $204M | 0.12% |
1,025,655
+63,952
| +7% | +$12.8M |
|
117
Deere & Co
DE
$175B
| $201M | 0.12% |
599,719
+591,236
| +6,970% | +$213M |
|
118
Invesco QQQ Trust
QQQ
$486B
| $200M | 0.12% |
557,998
+249,934
| +81% | +$92M |
|
119
PUT
Chevron
CVX
$403B
| $199M | 0.12% |
1,964,800
+415,300
| +27% | +$41.4M |
|
120
Lockheed Martin
LMT
$130B
| $194M | 0.12% |
561,512
+549,940
| +4,752% | +$199M |
|
121
PUT
FedEx
FDX
$76.9B
| $189M | 0.11% |
864,100
+409,200
| +90% | +$111M |
|
|
122
CALL
NVIDIA
NVDA
$5.2T
| $188M | 0.11% |
9,056,000
+3,336,000
| +58% | +$69.3M |
|
123
Berkshire Hathaway Class B
BRK.B
$1.06T
| $187M | 0.11% |
684,113
+257,100
| +60% | +$72.2M |
|
124
Analog Devices
ADI
$182B
| $186M | 0.11% |
1,108,660
+682,092
| +160% | +$114M |
|
125
PUT
MongoDB
MDB
$34.7B
| $185M | 0.11% |
393,200
+20,000
| +5% | +$8.06M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.